IL1B and colitis: Meanwhile, a significant decrease (P < 0.0001) in these parameters mentioned above was observed in the colitis + melatonin group (5 mg/kg, orally) (Improvement% for IL-1β -56.72%, for TNF-α -60.29%) compared with the colitis group without treatment.